anti-PD1-x-EGFR-BsAb (Sunshine GuoJian)

N/A

Report date: 2026/01/30 16:11:40

Base Information

Drug Nameanti-PD1-x-EGFR-BsAb (Sunshine GuoJian)
Drug Alias NameAnti-PD1/EGFRB bispecific antibody(Sunshine Guojian)anti-PD1-x-EGFR-BsAb
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionProgrammed cell death protein 1 blockersEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1Programmed cell death protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSunshine GuoJian Pharmaceutical (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSunshine GuoJian Pharmaceutical (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A